Retromer dysfunction in amyotrophic lateral sclerosis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35749364.
- Also identified by DOI 10.1073/pnas.2118755119 and PMC identifier 9245686.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Retromer is a heteropentameric complex that plays a specialized role in endosomal protein sorting and trafficking. Here, we report a reduction in the retromer proteins-vacuolar protein sorting 35 (VPS35), VPS26A, and VPS29-in patients with amyotrophic lateral sclerosis (ALS) and in the ALS model provided by transgenic (Tg) mice expressing the mutant superoxide dismutase-1 G93A. These changes are accompanied by a reduction of levels of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit GluA1, a proxy of retromer function, in spinal cords from Tg SOD1<sup>G93A</sup> mice. Correction of the retromer deficit by a viral vector expressing <i>VPS35</i> exacerbates the paralytic phenotype in Tg SOD1<sup>G93A</sup> mice. Conversely, lowering <i>Vps35</i> levels in Tg SOD1<sup>G93A</sup> mice ameliorates the disease phenotype. In light of these findings, we propose that mild alterations in retromer inversely modulate neurodegeneration propensity in ALS.
Medical subject headings
- Amyotrophic Lateral Sclerosis
- Vesicular Transport Proteins